Testing blood markers to explain clot risk in ITP
Part of Heart & circulation clinical trials.
This study looks at specific immune blood tests to understand why some people with immune thrombocytopenia (ITP) also develop blood clots. Results may help doctors better assess clot risk in ITP and sort out which antibodies are involved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult age 18 or older
- Have a confirmed diagnosis of primary chronic ITP
- You may be in the group with past thrombosis (blood clots) or without clots
- You should not have ITP caused by another condition (secondary ITP)
- You must not be pregnant or have uncontrolled high blood pressure
- You should not have major ongoing artery disease or serious liver/kidney test problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether certain proteins in the blood can help doctors diagnose immune thrombocytopenia (ITP), a condition where your immune system destroys platelets. It may help find a faster, simpler way to confirm ITP.
This study looks at blood and immune system patterns in adults with primary immune thrombocytopenia (ITP) who are starting their first treatment. The goal is to better understand what’s happening in ITP, which may improve how future patients are cared for.
This study looks at blood test antibodies to help confirm whether low platelet counts are caused by an autoimmune condition. It may help doctors better classify your type of low platelets and guide appropriate next steps.
This Phase 2 study tests how safe and effective PF-06835375 is for people with primary immune thrombocytopenia (ITP), a condition where platelet counts are too low. It may help reduce bleeding risk by improving platelet levels, depending on the results.
This study helps doctors better understand immune thrombocytopenia (ITP) by collecting basic patient information and, if you agree, storing blood samples. It may help future care decisions and research for people with ITP.
This study looks at whether people with immune thrombocytopenia (ITP) also have thyroid problems and if that affects their treatment. It could help doctors better understand and manage both conditions.
Hear when a new Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.